Idiopathic guttate hypomelanosis

From WikiMD's WELLNESSPEDIA


Idiopathic guttate hypomelanosis
Synonyms IGH
Pronounce N/A
Specialty N/A
Symptoms N/A
Complications N/A
Onset N/A
Duration N/A
Types N/A
Causes N/A
Risks N/A
Diagnosis N/A
Differential diagnosis N/A
Prevention N/A
Treatment N/A
Medication N/A
Prognosis N/A
Frequency N/A
Deaths N/A


Idiopathic guttate hypomelanosis (IGH) is a common skin condition characterized by small, white macules on the skin. These macules are typically round or oval and are most often found on the arms and legs.

Epidemiology[edit]

IGH is more prevalent in middle-aged and elderly individuals, particularly those with lighter skin types. It is estimated that up to 80% of people over the age of 70 may exhibit some degree of IGH.

Etiology[edit]

The exact cause of IGH is unknown, hence the term "idiopathic." However, it is believed to be related to the natural aging process and sun exposure. The condition is not associated with any systemic disease or malignancy.

Pathophysiology[edit]

IGH is thought to result from a reduction in the number of melanocytes in the affected areas. This leads to a decrease in melanin production, causing the characteristic white spots.

Clinical Features[edit]

IGH presents as multiple, discrete, hypopigmented macules that are usually 2-5 mm in diameter. These lesions are asymptomatic and do not cause any itching or pain.

Diagnosis[edit]

The diagnosis of IGH is primarily clinical, based on the appearance of the lesions. Dermatoscopy can aid in the diagnosis by revealing a characteristic "feathered" edge of the macules.

Differential Diagnosis[edit]

IGH should be differentiated from other causes of hypopigmentation, such as:

Management[edit]

There is no definitive treatment for IGH, as it is a benign condition. Some patients may seek treatment for cosmetic reasons. Options include:

Prognosis[edit]

IGH is a benign condition with no risk of malignancy. The macules are permanent but do not progress or cause any health problems.

Prevention[edit]

While IGH cannot be prevented, minimizing sun exposure and using sunscreen may help reduce the risk of developing new lesions.

See also[edit]

References[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.